Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

Development of membranoproliferative glomerulonephritis-like glomerulopathy in a patient with neutrophilia resulting from endogenous granulocyte-colony stimulating factor overproduction: a case report

Authors: Seigo Ito, Takahiro Uchida, Naoki Oshima, Takashi Oda, Hiroo Kumagai

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

The pathophysiologic role of exogenous granulocyte-colony stimulating factor (G-CSF) administration is reportedly linked to the progression of glomerulonephritis. However, the relationship between endogenous G-CSF overproduction and the progression of glomerulopathy has not been well investigated.

Case presentation

A 76-year-old woman presented with neutrophilia at a medical check-up and thorough examination revealed a high level of serum G-CSF. She subsequently developed mild renal dysfunction and proteinuria. Her renal biopsy showed lobulation of the glomeruli with mesangial proliferation and glomerular capillary walls with a double contour but no immune complex deposition, suggesting membranoproliferative glomerulonephritis-like glomerulopathy. Thereafter, her proteinuria levels fluctuated in parallel with the changes in her blood neutrophil count and finally reduced considerably in association with her decreased neutrophil count.

Conclusions

The unique features of this case suggest that endogenous overproduction of G-CSF could play an important role in the pathogenesis of active glomerulonephritis.
Literature
1.
go back to reference Deotare U, Al-Dawsari G, Couban S, Lipton JH. G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept. Bone Marrow Transplant. 2015;50:1150–6.CrossRef Deotare U, Al-Dawsari G, Couban S, Lipton JH. G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept. Bone Marrow Transplant. 2015;50:1150–6.CrossRef
2.
go back to reference Peddi VR, Hariharan S, Schroeder TJ, First MR. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients. Clin Transpl. 1996;10:20–3. Peddi VR, Hariharan S, Schroeder TJ, First MR. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients. Clin Transpl. 1996;10:20–3.
3.
go back to reference Magen D, Mandel H, Berant M, Ben-Izhak O, Zelikovic I. MPGN type I induced by granulocyte colony stimulating factor. Pediatr Nephrol. 2002;17:370–2.CrossRef Magen D, Mandel H, Berant M, Ben-Izhak O, Zelikovic I. MPGN type I induced by granulocyte colony stimulating factor. Pediatr Nephrol. 2002;17:370–2.CrossRef
4.
go back to reference Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994;88:723–30.CrossRef Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994;88:723–30.CrossRef
5.
go back to reference Sotomatsu M, Kanazawa T, Ogawa C, Watanabe T, Morikawa A. Complication of rapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim). Br J Haematol. 2000;110:234–5.CrossRef Sotomatsu M, Kanazawa T, Ogawa C, Watanabe T, Morikawa A. Complication of rapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim). Br J Haematol. 2000;110:234–5.CrossRef
6.
go back to reference Nasilowska-Adamska B, Perkowska-Ptasinska A, Tomaszewska A, Serwacka A, Marianska B. Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor. Int J Hematol. 2010;92:765–8.CrossRef Nasilowska-Adamska B, Perkowska-Ptasinska A, Tomaszewska A, Serwacka A, Marianska B. Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor. Int J Hematol. 2010;92:765–8.CrossRef
7.
go back to reference Batal I, Markowitz GS, Wong W, Avasare R, Mapara MY, Appel GB, et al. Filgrastim-induced crescentic transformation of recurrent IgG2λ GN. J Am Soc Nephrol. 2016;27:1911–5.CrossRef Batal I, Markowitz GS, Wong W, Avasare R, Mapara MY, Appel GB, et al. Filgrastim-induced crescentic transformation of recurrent IgG2λ GN. J Am Soc Nephrol. 2016;27:1911–5.CrossRef
8.
go back to reference Dagia NM, Gadhoum SZ, Knoblauch CA, Spencer JA, Zamiri P, Lin CP, et al. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat Med. 2006;12:1185–90.CrossRef Dagia NM, Gadhoum SZ, Knoblauch CA, Spencer JA, Zamiri P, Lin CP, et al. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat Med. 2006;12:1185–90.CrossRef
9.
go back to reference Sloand EM. Soluble urokinase activator receptor (suPAR) in stem cell mobilization. Blood. 2005;105:1847–8.CrossRef Sloand EM. Soluble urokinase activator receptor (suPAR) in stem cell mobilization. Blood. 2005;105:1847–8.CrossRef
10.
go back to reference Kitching AR, Ru Huang X, Turner AL, Tipping PG, Dunn AR, Holdsworth SR. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J Am Soc Nephrol. 2002;13:350–8.PubMed Kitching AR, Ru Huang X, Turner AL, Tipping PG, Dunn AR, Holdsworth SR. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J Am Soc Nephrol. 2002;13:350–8.PubMed
11.
go back to reference Gallon L, disease QSEG. A suPAR kidney connection found in the bone marrow. Nat Rev Nephrol. 2017;13:263–4.CrossRef Gallon L, disease QSEG. A suPAR kidney connection found in the bone marrow. Nat Rev Nephrol. 2017;13:263–4.CrossRef
12.
go back to reference Hahm E, Wei C, Fernandez I, Li J, Tardi NJ, Tracy M, et al. Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nat Med. 2017;23:100–6.CrossRef Hahm E, Wei C, Fernandez I, Li J, Tardi NJ, Tracy M, et al. Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nat Med. 2017;23:100–6.CrossRef
13.
go back to reference Erbas O, Yapislar H, Oltulu F, Yavasoğlu A, Aktug H, Taskiran D. Nephro-protective effect of granulocyte colony-stimulating factor in streptozotocin induced diabetic rats. Biotech Histochem. 2014;89:488–96.CrossRef Erbas O, Yapislar H, Oltulu F, Yavasoğlu A, Aktug H, Taskiran D. Nephro-protective effect of granulocyte colony-stimulating factor in streptozotocin induced diabetic rats. Biotech Histochem. 2014;89:488–96.CrossRef
14.
go back to reference Yasui H, Sato K, Takeyama Y, Ando A, Kato T, Hashimoto H, et al. Granulocyte colony-stimulating factor-producing carcinoma of unknown primary site. Case Rep Oncol. 2014;7:780–8.CrossRef Yasui H, Sato K, Takeyama Y, Ando A, Kato T, Hashimoto H, et al. Granulocyte colony-stimulating factor-producing carcinoma of unknown primary site. Case Rep Oncol. 2014;7:780–8.CrossRef
15.
go back to reference Morooka M, Kubota K, Murata Y, Shibuya H, Ito K, Mochizuki M, et al. (18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors. Ann Nucl Med. 2008;22:635–9.CrossRef Morooka M, Kubota K, Murata Y, Shibuya H, Ito K, Mochizuki M, et al. (18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors. Ann Nucl Med. 2008;22:635–9.CrossRef
16.
go back to reference Jadus MR, Pai R, Horansky E, Wepsic HT, Kirschenbaum MA, Kamanna VS. Hematopoietic colony stimulatory factor formation by murine mesangial cells: gene expression and biological activity. Biochim Biophys Acta. 1994;1224:181–8.CrossRef Jadus MR, Pai R, Horansky E, Wepsic HT, Kirschenbaum MA, Kamanna VS. Hematopoietic colony stimulatory factor formation by murine mesangial cells: gene expression and biological activity. Biochim Biophys Acta. 1994;1224:181–8.CrossRef
17.
go back to reference Saigusa T, Kikuchi Y, Yamada M, Imakiire T, Hyodo T, Suzuki S, et al. A case of essential thrombocytosis developing nephrotic syndrome and severe endothelial damage. J Nephrol. 2006;19:656–9.PubMed Saigusa T, Kikuchi Y, Yamada M, Imakiire T, Hyodo T, Suzuki S, et al. A case of essential thrombocytosis developing nephrotic syndrome and severe endothelial damage. J Nephrol. 2006;19:656–9.PubMed
18.
go back to reference Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP, et al. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int. 2011;80:753–9.CrossRef Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP, et al. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int. 2011;80:753–9.CrossRef
19.
go back to reference Sethi S, Rajkumar SV, D'Agati VD. The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Soc Nephrol. 2018;29:1810–23.CrossRef Sethi S, Rajkumar SV, D'Agati VD. The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Soc Nephrol. 2018;29:1810–23.CrossRef
Metadata
Title
Development of membranoproliferative glomerulonephritis-like glomerulopathy in a patient with neutrophilia resulting from endogenous granulocyte-colony stimulating factor overproduction: a case report
Authors
Seigo Ito
Takahiro Uchida
Naoki Oshima
Takashi Oda
Hiroo Kumagai
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1049-4

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.